Robert Barrie is a journalist specializing in the medical and pharmaceutical industries. He writes for publications such as Medical Device Network, Pharmaceutical-Technology, and Clinical Trials Arena, covering topics ranging from new medical devices and therapies to clinical trial advancements. His work has also been featured in The Redstone Rocket.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Robert Barrie appears to focus extensively on the healthcare and pharmaceutical industry, with a particular emphasis on company announcements and press releases. To effectively reach out to Robert, consider providing insights or exclusive information related to major developments within the pharmaceutical industry such as clinical trial results, FDA decisions, medical device advancements or biotech startup breakthroughs.
As Robert's coverage heavily features private sector announcements and press releases, ensure that any pitch includes newsworthy updates backed by credible sources. Additionally, offering exclusive interviews with key figures in the healthcare and pharmaceutical sector could increase the chances of successful outreach.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Robert Barrie
BMS's CFO David Elkin added it is “too soon to tell” what policies Trump’s new administration will bring.
ŌURA, which is now valued at more than $5bn, is set to integrate Dexcom's glucose capabilities with the Oura ring.
By: Robert Barrie
UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragmented” NHS at the Jefferies London Healthcare Conference.
By: Robert Barrie
UK Health Secretary Wes Streeting outlaid the key shifts needed to fix a “fragmented” NHS at the Jefferies London Healthcare Conference.
2 min read UK Secretary of Health and Social Care Wes Streeting has placed data at the heart of the government's plan to fix the National Health Service (NHS) which he says is at its “worst crisis in history”.
By: Robert Barrie
The first mpox vaccine authorised for children will be shipped to DRC in a 3.05 million-dose donation by the Japanese Government.
By: Robert Barrie
The Omnipod 5, which already connects with Dexcom’s CGMs, now boasts Abbott’s flagship diabetes product.
By: Robert Barrie
RFK Jr has vowed to shake up the FDA, but the CBER head said support for the agency's public health mission continues.
By: Robert Barrie
Novo Nordisk and Ypsomed's 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.
By: Robert Barrie
Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema.
(833) 317-6278 
